Ab1038 Erythrocyte Sedimentation Rate as a Biomarker in Sle

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1OP0255 SELECT SOLUBLE MEDIATORS INFORM A REFINED LUPUS DISEASE ACTIVITY IMMUNE INDEX THAT CHARACTERIZES CLINICAL DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS2024
2. 2AB0982 DOMAINS FOR INCLUSION IN A NOVEL TREATMENT RESPONSE MEASURE FOR SYSTEMIC LUPUS ERYTHEMATOSUS (TRM-SLE): RESULTS OF A MODIFIED DELPHI STUDY2024
3. 3POS0191 A LUPUS FLARE RISK INDEX INFORMED BY SELECT ADAPTIVE AND TNF SUPERFAMILY IMMUNE MEDIATORS: VALIDATION IN A CONFIRMATORY COHORT2024 · 1 citations
4. 4OP0013 ANTI-Ro/SSA ANTIBODIES ARE PREDICTIVE OF A MORE SEVERE LUNG INVOLVEMENT IN PATIENTS WITH SYSTEMIC SCLEROSIS: A STUDY FROM THE EUSTAR HDATABASE2024 · 3 citations
5. 5P145 Feasibility of assessing systemic lupus erythematosus related damage using UK electronic health record data and associations with mortality2026